- Home
- HIPO vs KURA Comparison
HIPO vs KURA Comparison
Compare HIPO & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIPO | KURA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.5M | 830.1M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HIPO | KURA |
|---|---|---|
| Price | $28.49 | $8.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $37.50 | $26.88 |
| AVG Volume (30 Days) | 112.7K | ★ 1.3M |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,883,000.00 |
| Revenue This Year | $28.91 | $88.72 |
| Revenue Next Year | $17.89 | $60.02 |
| P/E Ratio | $7.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.92 | $5.41 |
| 52 Week High | $38.98 | $12.49 |
Technical Indicators
Market Signals| Indicator | HIPO | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 47.78 |
| Support Level | $27.99 | $7.50 |
| Resistance Level | $29.02 | $8.70 |
| Average True Range (ATR) | 0.85 | 0.34 |
| MACD | -0.04 | 0.14 |
| Stochastic Oscillator | 29.91 | 79.44 |
Price Performance
Historical ComparisonAbout HIPO Hippo Holdings Inc.
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.